Vilon (20mg Vial) Dosage Protocol
Contents
Quickstart Highlights
Vilon (Lys‑Glu) is a synthetic immunoregulatory dipeptide consisting of lysine and glutamic acid residues[1]. Preclinical research indicates it may enhance immune markers including CD5+ lymphocytes and interleukin‑2 expression in thymic and splenic cell cultures[2][3]. This educational protocol presents a pulsed subcutaneous approach (5 consecutive days per 4‑week cycle) using a practical dilution for clear insulin‑syringe measurements.
- Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
- Typical range: 67–670 mcg once daily for 5 consecutive days per cycle.
- Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 1 week or aliquot and freeze.
Dosing & Reconstitution Guide
Standard / Gradual Approach (3 mL = ~6.67 mg/mL)
Schedule: Inject once daily subcutaneously for 5 consecutive days, then rest for the remainder of a 4‑week cycle. Repeat monthly[4][5].
| Phase / Cycle | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Cycle 1, Day 1 | 67 mcg (0.067 mg) | 1 unit (0.01 mL) |
| Cycle 1, Day 2 | 133 mcg (0.133 mg) | 2 units (0.02 mL) |
| Cycle 1, Day 3 | 200 mcg (0.20 mg) | 3 units (0.03 mL) |
| Cycle 1, Day 4 | 267 mcg (0.267 mg) | 4 units (0.04 mL) |
| Cycle 1, Day 5 | 333 mcg (0.33 mg) | 5 units (0.05 mL) |
| Cycle 2+ (Days 1–5) | 333–667 mcg (0.33–0.67 mg) | 5–10 units (0.05–0.10 mL) |
For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within ~1 week or aliquot and freeze[10].
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week pulsed protocol (5 injection days per 4‑week cycle).
- Peptide Vials (Vilon, 20 mg each):
- 8 weeks (2 cycles, 10 injections) ≈ 1 vial
- 12 weeks (3 cycles, 15 injections) ≈ 1 vial
- 16 weeks (4 cycles, 20 injections) ≈ 1 vial
- Insulin Syringes (U‑100, 30‑ or 50‑unit preferred):
- Per cycle: 5 syringes (1/day × 5 days)
- 8 weeks: 10 syringes
- 12 weeks: 15 syringes
- 16 weeks: 20 syringes
- Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
- 8–16 weeks (1 vial): 3 mL → 1 × 10 mL bottle
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per cycle: 10 swabs (2/day × 5 days)
- 8 weeks: 20 swabs
- 12 weeks: 30 swabs
- 16 weeks: 40 swabs → recommend 1 × 100‑count box
Protocol Overview
Concise summary of the pulsed regimen.
- Goal: Support immune modulation and thymic function markers based on preclinical observations[1][2].
- Schedule: 5 consecutive days of subcutaneous injections per 4‑week cycle; repeat for 2–4 cycles.
- Dose Range: 67–667 mcg daily with gradual titration during the first cycle.
- Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate low‑volume measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Dosing Protocol
Suggested pulsed titration approach.
- Start: 67 mcg (1 unit) on Day 1; increase by ~67 mcg (1 unit) each day during first cycle.
- Target: 333–667 mcg (5–10 units) daily by Cycle 2 onward.
- Frequency: Once per day (subcutaneous) for 5 consecutive days per cycle[5].
- Cycle Length: 5 days on, ~23 days off (4‑week cycle); run 2–4 cycles.
- Timing: Any consistent time; rotate injection sites.
Storage Instructions
Proper storage preserves peptide quality.
- Lyophilized: Store at −20 °C (−4 °F) short‑term or −80 °C (−112 °F) long‑term in dry, dark conditions; minimize moisture exposure[10].
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within ~1 week or prepare aliquots and freeze to extend stability.
- Allow vials to reach room temperature before opening to reduce condensation uptake.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes (30‑ or 50‑unit recommended for low‑volume accuracy); dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[9].
- Inject slowly; wait a few seconds before withdrawing the needle.
- Document daily dose and site rotation to maintain consistency across cycles.
How This Works
Vilon belongs to a class of short bioregulatory peptides developed through Russian gerontology research[4]. In vitro studies demonstrate that the Lys‑Glu dipeptide can modulate lymphocyte populations and cytokine gene expression. Specifically, Vilon has been observed to increase CD5+ cell counts in thymus cell cultures[1] and upregulate interleukin‑2 (IL‑2) mRNA expression in splenocyte preparations[2]. Additional preclinical work suggests effects on TGF‑β1 and vascular permeability in renal models[3]. The pulsed 5‑day monthly regimen is analogized from related short peptide protocols such as Epitalon[5].
Potential Benefits & Side Effects
Observations from preclinical literature.
- Supports immune cell marker expression (CD5+ lymphocytes) and IL‑2 gene activity in cell culture models[1][2].
- May modulate inflammatory cytokines such as TGF‑β1 under experimental renal stress conditions[3].
- Early mouse studies suggest potential effects on tumor growth inhibition and lifespan extension, though human data remain limited[6].
- Generally well tolerated in preclinical settings; occasional mild injection‑site reactions (redness/itch) may occur with subcutaneous administration.
Lifestyle Factors
Complementary strategies for best outcomes.
- Pair with a nutrient‑dense diet rich in antioxidants and adequate protein to support immune function.
- Incorporate regular moderate exercise to reinforce immune and metabolic health.
- Prioritize sleep (7–9 hours) and stress management to optimize endogenous immune regulation.
Injection Technique
General subcutaneous guidance from clinical best‑practice resources[9].
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[7][8].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[9].
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[9].
Recommended Source
Why Amino Labs?
- Third-party tested: Each batch includes Certificate of Analysis (COA) verifying purity and composition.
- Consistent quality: ISO-aligned manufacturing and handling standards ensure reliable product integrity.
- Cold-chain integrity: Temperature-controlled shipping and storage throughout fulfillment process.
- Research-grade purity: Suitable for educational and research applications requiring high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Important Note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.
References
— In vitro effect of short peptides on expression of interleukin‑2 gene in splenocytes
— Effect of Vilon peptide on TGF‑β1 and vascular permeability in chronic renal failure
— Effect of a peptide Vilon on immune aging (Adv Gerontol)
— Overview of Epitalon—highly bioactive pineal tetrapeptide with promising properties (Int J Mol Sci)
— Synthetic dipeptide Vilon inhibits tumor growth and prolongs life in mice (Dokl Biol Sci)
— Peptides regulating proliferative activity and inflammatory pathways in THP‑1 macrophages (Int J Mol Sci)
— Injection techniques to reduce subcutaneous heparin complications (J Adv Nurs)
— Subcutaneous (SQ) injections: patient information
— Handling and storage guidelines for peptides and proteins
— Vaccine administration: subcutaneous route (angle/site; no aspiration)
— Best practices for injection (asepsis, preparation, and administration)

![insulin[1] insulin[1]](https://peptidedosing.ca/wp-content/uploads/2026/01/insulin1-178x178.webp)
![Bacteriostatic-Water-Bottle[1] Bacteriostatic-Water-Bottle[1]](https://peptidedosing.ca/wp-content/uploads/2026/01/Bacteriostatic-Water-Bottle1-178x178.webp)
![EasyTouch_Alcohol_Pads[1] EasyTouch_Alcohol_Pads[1]](https://peptidedosing.ca/wp-content/uploads/2026/01/EasyTouch_Alcohol_Pads1-178x178.avif)